AE Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

AE Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,207	Closed	-$11.7K	–	2036
2022 Q4	$11.7K	Sell	13,207 -500	-4%	-$663	﹤0.01%	1794
2022 Q3	$22K	Buy	13,707 +32	+0.2%	+$73	﹤0.01%	1714
2022 Q2	$27K	Sell	13,675 -100	-0.7%	-$173	﹤0.01%	1695
2022 Q1	$32K	Buy	13,775 +1,219	+10%	+$3.8K	﹤0.01%	1646
2021 Q4	$58K	Sell	12,556 -2,105	-14%	-$13.1K	﹤0.01%	1656
2021 Q3	$112K	Buy	14,661 +2,126	+17%	+$18K	﹤0.01%	1552
2021 Q2	$121K	Buy	+12,535	New	+$99.8K	﹤0.01%	1525

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return